×
About 10,115 results

ALLMedicine™ Eczema Center

Research & Reviews  2,611 results

Successful treatment of tinea capitis caused by Microsporum canis in a 23-day-old newbo...
https://doi.org/10.1111/dth.15078
Dermatologic Therapy; Zhou YB, Xiao YY et. al.

Jul 31st, 2021 - Although tinea capitis is common in children, but it is rare in newborns. It should be differentiated with neonatal lupus erythematosus, nummular eczema, psoriasis, seborrheic dermatitis, erythema annular centrifugum, annular urticaria, and annula...

Associations between home renovation and asthma, allergic rhinitis, and eczema among pr...
https://doi.org/10.1080/09603123.2021.1955832
International Journal of Environmental Health Research; Ren X, Liu Y et. al.

Jul 30th, 2021 - To investigate the potential associations between household renovation and allergic diseases among preschool children in Wuhan, we conducted a large cross-sectional questionnaire survey among 9455 preschool children aged 3-6 years in Wuhan during ...

Prevention of infant eczema by neonatal Bacillus Calmette-Guérin vaccination: the MIS B...
https://doi.org/10.1111/all.15022
Allergy Pittet LF, Messina NL et. al.

Jul 27th, 2021 - Bacille Calmette-Guérin (BCG) vaccine could play a role in counteracting the rising prevalence of atopic diseases, through its beneficial off-target effects. We aimed to determine whether neonatal BCG vaccination reduces the incidence of eczema in...

Increased prevalence of irritant hand eczema in health care workers in a dermatological...
https://doi.org/10.1684/ejd.2021.4046
European Journal of Dermatology : EJD; Reinholz M, Kendziora B et. al.

Jul 27th, 2021 - Hand hygiene measures in the general population and in health care workers have increased considerably since the outbreak of the COVID-19 pandemic. To investigate the prevalence and symptoms of hand eczema, as well as hygiene measures and concepts...

Four subtypes of childhood allergic rhinitis identified by latent class analysis.
https://doi.org/10.1111/pai.13605
Pediatric Allergy and Immunology : Official Publication O... Yavuz ST, Oksel Karakus C et. al.

Jul 27th, 2021 - Childhood allergic rhinitis (AR) is clinically heterogeneous. We aimed to identify distinct phenotypes amongst children with AR using data-driven techniques, and to ascertain their association with patterns of symptoms, allergic sensitization and ...

see more →

Guidelines  4 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) ...
https://doi.org/10.1111/jdv.14891
Journal of the European Academy of Dermatology and Venere... Wollenberg A, Barbarot S et. al.

Apr 21st, 2018 - This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic revi...

BSACI guideline for the diagnosis and management of peanut and tree nut allergy.
https://doi.org/10.1111/cea.12957
Clinical and Experimental Allergy : Journal of the Britis... Stiefel G, Anagnostou K et. al.

Aug 25th, 2017 - Peanut nut and tree nut allergy are characterised by IgE mediated reactions to nut proteins. Nut allergy is a global disease. Limited epidemiological data suggest varying prevalence in different geographical areas. Primary nut allergy affects over...

Guideline for the management of wounds in patients with lower-extremity venous disease:...
https://doi.org/10.1097/WON.0b013e31827179e9
Journal of Wound, Ostomy, and Continence Nursing : Offici... Kelechi TJ, Johnson JJ et. al.

Nov 10th, 2012 - This article provides an executive summary of the lower extremity venous disease (LEVD) evidence-based guideline produced by the WOCN Wound Guidelines Task Force. The target audience for this guideline is health care professionals who specialize i...

see more →

Drugs  703 results see all →

Clinicaltrials.gov  121 results

Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection
https://clinicaltrials.gov/ct2/show/NCT00006150

May 5th, 2020 - The Hyper IgE Syndromes (HIES) are primary immunodeficiencies resulting in eczema and recurrent skin and lung infections. Autosomal dominant Hyper IgE syndrome (AD-HIES; Job's syndrome) is caused by STAT3 mutations, and is a multi-system disorder ...

The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants
https://clinicaltrials.gov/ct2/show/NCT03667651

Mar 25th, 2020 - The primary objective of this study is to demonstrate that twice daily application of a ceramide dominant emollient reduces the risk of eczema and food allergy, when compared to standard skin management. Secondary objectives are to determine if tw...

EARLYEMOLLIENT - Feasibility of Early Emollient Use in Children With Atopic Eczema
https://clinicaltrials.gov/ct2/show/NCT03376243

Mar 9th, 2020 - The aim of this trial is to determine the reasons that motivate parents to enrol or not enrol their child in a randomized, controlled basic emollient trial for the prevention of AE. Furthermore, this trial intends to test the hypothesis that daily...

Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema
https://clinicaltrials.gov/ct2/show/NCT00442091

Mar 4th, 2020 - Dandelion juice has been used in herbal medicine for at least 1000 years. One case report has shown a beneficial effect of this herbal remedy on dyshidrotic hand eczema, and the purpose of this pilot study is to test whether this effect can be ret...

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema
https://clinicaltrials.gov/ct2/show/NCT03683719

Feb 27th, 2020 - This is a double-blind, multi-centre, randomised, 5-arm, vehicle-controlled, parallel-group trial. The trial is designed to establish a dose-response signal and to investigate the efficacy and safety of delgocitinib cream in the treatment of adult...

see more →

News  575 results

AbbVie, Lilly Face Fresh Delays in FDA Approval for Expanded Use of Arthritis Drugs
https://www.medscape.com/viewarticle/954936

Jul 19th, 2021 - (Reuters) - AbbVie Inc and Eli Lilly & Co are facing fresh delays in the approval of their respective rheumatoid arthritis drugs for treating the chronic skin disease eczema as the U.S. health regulator assesses the new class of treatment over saf...

Adopt a Stepped Approach to Atopic Eczema Management
https://www.medscape.com/viewarticle/954599

Jul 13th, 2021 - Dr Caroline Ward Dr Caroline Ward, GP and standing member of the National Institute for Health and Care Excellence (NICE) Managing Common Infections Advisory Committee, discusses NICE recommendations on the treatment of atopic eczema, focusing on ...

UV Light Linked to Prevention of Allergic Disease in Infants
https://www.medscape.com/viewarticle/954650

Jul 12th, 2021 - Higher direct ultraviolet (UV) light exposure in the first 3 months of life was linked to lower incidence of proinflammatory immune markers and lower incidence of eczema in an early-stage double-blind, randomized controlled trial.   Kristina Ruete...

Survey Spotlights the Out-of-Pocket Burden on Blacks With Atopic Dermatitis
https://www.medscape.com/viewarticle/953885

Jun 28th, 2021 - Compared with their non-Black counterparts, Black patients with atopic dermatitis (AD) are significantly more likely to be younger, have lower household incomes, live in an urban setting, and use Medicaid or state assistance. They also have signif...

12-Month Follow-Up Shows Monthly Maintenance Dose of Tralokinumab Maintains Response in Some Patients With AD
https://www.medscape.com/viewarticle/953480

Jun 21st, 2021 - Dr Andrew Blauvelt A large proportion of initial Investigator Global Assessment (IGA) 0/1 or Eczema Area and Severity Index (EASI) 75 responders at week 16 maintained response with continued tralokinumab dosing every 2 weeks or every 4 weeks durin...

see more →

Patient Education  32 results see all →